Skip to main content
. 2019 Jan 10;2019:6107217. doi: 10.1155/2019/6107217

Figure 1.

Figure 1

Unadjusted two-year retention rate of tumor necrosis factor inhibitors (TNFis) according to baseline Rheumatic Disease Comorbidity Index (RDCI).